의료용 인공호흡기 시장 : 시장 점유율 분석, 업계 동향 및 통계, 성장 예측(2026-2031년)

According to Mordor Intelligence, the medical ventilator market size is expected to increase from USD 3.06 billion in 2025 to USD 3.25 billion in 2026 and reach USD 4.33 billion by 2031, growing at a CAGR of 5.91% over 2026-2031.

This report is Segmented by Product Type (Critical Care, Neonatal, Transport and Portable, Home Care), Interface (Invasive, Non-Invasive), Technology (Conventional, Intelligent/Closed-Loop, Turbine-Based), End User (Hospitals, Home Care Settings, Ambulatory Surgical Centers, Emergency Providers), and Geography (North America, Europe, Asia-Pacific, MEA, South America). Forecasts in Value (USD).

Global Medical Ventilator Market Trends and Insights

Rising Burden Of Chronic Respiratory Diseases

Chronic respiratory diseases, particularly COPD and acute respiratory distress cases, are the primary drivers of demand in the medical ventilator market. In 2025, the Global Burden of Disease Study highlighted 569.2 million cases of chronic respiratory diseases globally, underscoring the vast treatment pool in both advanced and developing health systems. The WHO pointed out that chronic respiratory diseases pose a significant mortality challenge in South-East Asia, linking ventilation demand to routine care rather than just emergencies. Furthermore, the WHO and ERS highlighted that Europe underdiagnoses chronic respiratory diseases, with COPD responsible for 80% of related deaths. This suggests a substantial future demand not yet reflected in current procurement trends. As screening and diagnosis improve in middle-income countries, there's a potential shift from a hidden demand to active purchasing in the medical ventilator market, particularly in the Asia-Pacific region.

Aging Population Requiring Assisted Ventilation

Older adults, who frequently face challenges like COPD and post-surgical respiratory failures, are a significant demographic driving the medical ventilator market. The WHO, in October 2024, projected that by mid-century, 80% of the world's elderly population will reside in developing nations. This trend indicates a growing care burden in regions still enhancing their respiratory care capabilities. Given their weaker respiratory muscles and multiple health challenges, older patients often experience prolonged ventilator use in hospitals. This extended usage can slow ICU bed turnover, prompting healthcare providers to seek devices that facilitate both immediate stabilization and a smoother recovery. Moreover, a significant number of elderly patients require continued respiratory support post-discharge, bolstering the demand for home respiratory assistance.

High Total Cost Of Ownership And Service Burden

The medical ventilator market faces significant cost challenges, as ownership involves more than just the purchase price. High-acuity critical care systems cost between USD 5,000 and over USD 50,000 per unit, with additional expenses for calibration, consumables, servicing, software updates, and repairs. Public hospitals and resource-limited systems, operating under tight budgets, find these costs difficult to manage. Rapid technology advancements make older units appear outdated before their hardware lifecycle ends, pushing buyers toward rental models and bundled service contracts. While these models aid adoption, they delay one-time hardware revenue realization in the market.

Other drivers and restraints analyzed in the detailed report include:

1. Expansion Of Home-Based Non-Invasive Ventilation
2. Replacement Demand For Connected And Smart Ventilators
3. Reimbursement Pressure On Long-Term Home Ventilation

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

In 2025, critical care ventilators held a 44.58% share of the medical ventilator market, driven by their essential role in ICU admissions requiring high-acuity and complex ventilation. These ventilators are critical for invasive ventilation, perioperative care, and prolonged respiratory support, where reliability and multi-mode capabilities are vital. Hospitals prioritize these systems in capital planning due to their importance in critical care readiness and emergency response, ensuring a strong installed base despite selective procurement trends. This category remains indispensable in tertiary care settings.

Transport and portable ventilators are the fastest-growing segment, with a projected 6.72% CAGR from 2026 to 2031. This growth reflects the industry's shift toward mobility, distributed care, and uninterrupted respiratory support across locations. Demand is rising for battery-efficient turbine systems capable of maintaining stable performance during emergency transport, military operations, and intrahospital transfers. Clinical advancements in adaptive minute ventilation further enhance the role of portable devices, positioning them as a significant segment in the medical ventilator market.

In 2025, invasive ventilation accounted for 64.88% of the medical ventilator market, underscoring its critical role in ICU care, emergency stabilization, and post-surgical respiratory management. Endotracheal intubation and tracheostomy-based support remain essential for patients unable to maintain ventilation or airway protection, keeping invasive systems central to hospital purchasing and clinical workflows. This segment continues to dominate despite the growing adoption of non-invasive care.

Non-invasive ventilation is the fastest-growing interface segment, with a 6.45% CAGR expected from 2026 to 2031. Its growth stems from expanding applications in acute care, post-surgical recovery, and long-term COPD management. Evolving care standards and next-generation features enhancing clinical usability are driving broader adoption. Combined with expanded home reimbursement policies, non-invasive support is poised for significant growth in the medical ventilator market.

Complete Report Scope:

• By Product Type
  • Critical Care Ventilators
  • Neonatal Ventilators
  • Transport and Portable Ventilators
  • Home Care Ventilators
• By Interface
  • Invasive Ventilation
  • Non-Invasive Ventilation
• By Technology
  • Conventional Ventilators
  • Intelligent and Closed-Loop Ventilators
  • Turbine-Based Ventilators
• By End User
  • Hospitals
  • Home Care Settings
  • Ambulatory Surgical Centers
  • Emergency and Prehospital Care Providers
• By Geography
  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • Middle East and Africa
    • GCC
    • South Africa
    • Rest of Middle East and Africa
  • South America
    • Brazil
    • Argentina
    • Rest of South America

Geography Analysis

In 2025, North America held 38.99% of the medical ventilator market share, driven by a strong ICU infrastructure, established reimbursement systems, and rapid adoption of software-integrated ventilation platforms. The U.S. leads demand as hospitals upgrade to advanced critical care systems, supported by the June 2025 CMS decision expanding home non-invasive support beyond acute settings. This creates a balanced demand mix across high-acuity hospital care and post-discharge respiratory management. Canada and Mexico also contribute to growth through infrastructure investments and fleet upgrades. However, administrative challenges, such as documentation quality and billing discipline, remain barriers to smoother reimbursement processes.

Europe, a mature yet evolving market, is expected to add over USD 430 million in value between 2026 and 2031. Germany anchors the market with a strong manufacturing base and steady hospital replacement demand. Drager reported record net sales of EUR 3 billion in fiscal 2025, with its medical division order intake growing 8.9% to EUR 2,046.6 million (approximately USD 2.21 billion). Stricter EU device regulations are increasing compliance and post-market surveillance costs, pressuring smaller manufacturers. Fisher & Paykel Healthcare demonstrated growth in recurring revenue, with FY2026 hospital product group revenue reaching NZD 1.51 billion (approximately USD 906 million), up 18% year over year.

Asia-Pacific is the fastest-growing region in the medical ventilator market, with an 8.12% CAGR projected from 2026 to 2031. Growth is fueled by government-led ICU expansions, aging populations, and a stronger domestic manufacturing base in countries like China and India. In 2025, China's public hospitals procured 17,448 ventilators worth CNY 2.65 billion (approximately USD 365 million), with Mindray Bio-Medical holding a 40.74% value share, followed by Drager at 15.62% and KOMAN at 12.43%. These top three brands controlled 68.79% of the domestic public procurement market. China's 15th Five-Year Plan in 2026 supports domestic high-end medical equipment development, intensifying local competition. India and Indonesia also drive growth through local manufacturing partnerships and increased in-country value addition.

1. Air Liquide S.A.
2. Beckton Dickinson
3. Dragerwerk AG and Co. KGaA
4. Fisher and Paykel Healthcare Corporation Limited
5. GE HealthCare Technologies Inc.
6. Getinge
7. Hamilton Medical
8. ICU Medical
9. Inspiration Healthcare Group plc
10. Koninklijke Philips
11. Lowenstein Medical Technology GmbH + Co. KG
12. Medtronic
13. Nihon Kohden
14. Resmed
15. Mindray
16. Skanray Technologies Private Limited
17. Teleflex
18. Vyaire Medical
19. Zoll Medical

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 Study Assumptions and Market Definition
• 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET LANDSCAPE

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 Rising Burden of Chronic Respiratory Disease and ICU Admissions
  • 4.2.2 Aging Population Requiring Assisted Ventilation
  • 4.2.3 Expansion of Home-Based Non-Invasive Ventilation
  • 4.2.4 Replacement Demand for Connected and Smart Ventilators
  • 4.2.5 Need for Supply Chain Localization in Critical Care Equipment
  • 4.2.6 Risk-Adjusted Procurement Favoring Multi-Mode Ventilation Platforms
• 4.3 Market Restraints
  • 4.3.1 High Total Cost of Ownership and Service Burden
  • 4.3.2 Reimbursement Pressure on Long-Term Home Ventilation
  • 4.3.3 Regulatory Recertification and Compliance Delays
  • 4.3.4 Under-Reporting of Ventilator Demand Outside Large Hospital Networks
• 4.4 Supply/Value Chain Analysis
• 4.5 Regulatory Landscape
• 4.6 Technological Outlook
• 4.7 Porter's Five Forces Analysis
  • 4.7.1 Bargaining Power of Buyers
  • 4.7.2 Bargaining Power of Suppliers
  • 4.7.3 Threat of New Entrants
  • 4.7.4 Threat of Substitutes
  • 4.7.5 Intensity of Competitive Rivalry

5 MARKET SIZE AND GROWTH FORECASTS (VALUE, USD)

• 5.1 By Product Type
  • 5.1.1 Critical Care Ventilators
  • 5.1.2 Neonatal Ventilators
  • 5.1.3 Transport and Portable Ventilators
  • 5.1.4 Home Care Ventilators
• 5.2 By Interface
  • 5.2.1 Invasive Ventilation
  • 5.2.2 Non-Invasive Ventilation
• 5.3 By Technology
  • 5.3.1 Conventional Ventilators
  • 5.3.2 Intelligent and Closed-Loop Ventilators
  • 5.3.3 Turbine-Based Ventilators
• 5.4 By End User
  • 5.4.1 Hospitals
  • 5.4.2 Home Care Settings
  • 5.4.3 Ambulatory Surgical Centers
  • 5.4.4 Emergency and Prehospital Care Providers
• 5.5 By Geography
  • 5.5.1 North America
    • 5.5.1.1 United States
    • 5.5.1.2 Canada
    • 5.5.1.3 Mexico
  • 5.5.2 Europe
    • 5.5.2.1 Germany
    • 5.5.2.2 United Kingdom
    • 5.5.2.3 France
    • 5.5.2.4 Italy
    • 5.5.2.5 Spain
    • 5.5.2.6 Rest of Europe
  • 5.5.3 Asia-Pacific
    • 5.5.3.1 China
    • 5.5.3.2 India
    • 5.5.3.3 Japan
    • 5.5.3.4 Australia
    • 5.5.3.5 South Korea
    • 5.5.3.6 Rest of Asia-Pacific
  • 5.5.4 Middle East and Africa
    • 5.5.4.1 GCC
    • 5.5.4.2 South Africa
    • 5.5.4.3 Rest of Middle East and Africa
  • 5.5.5 South America
    • 5.5.5.1 Brazil
    • 5.5.5.2 Argentina
    • 5.5.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

• 6.1 Market Concentration
• 6.2 Market Share Analysis
• 6.3 Company Profiles (includes Global Level Overview, Market Level Overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share, Products and Services, Recent Developments)
  • 6.3.1 Air Liquide S.A.
  • 6.3.2 Becton, Dickinson and Company
  • 6.3.3 Dragerwerk AG and Co. KGaA
  • 6.3.4 Fisher and Paykel Healthcare Corporation Limited
  • 6.3.5 GE HealthCare Technologies Inc.
  • 6.3.6 Getinge AB
  • 6.3.7 Hamilton Medical AG
  • 6.3.8 ICU Medical, Inc.
  • 6.3.9 Inspiration Healthcare Group plc
  • 6.3.10 Koninklijke Philips N.V.
  • 6.3.11 Lowenstein Medical Technology GmbH + Co. KG
  • 6.3.12 Medtronic plc
  • 6.3.13 Nihon Kohden Corporation
  • 6.3.14 ResMed Inc.
  • 6.3.15 Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • 6.3.16 Skanray Technologies Private Limited
  • 6.3.17 Teleflex Incorporated
  • 6.3.18 Vyaire Medical, Inc.
  • 6.3.19 ZOLL Medical Corporation

7 MARKET OPPORTUNITIES AND FUTURE OUTLOOK

• 7.1 White-Space and Unmet-Need Assessment